A total of 108 patients with NSCLC were treated with anti‐PD‐(L)1 monotherapy agents at Sun Yat‐sen University Cancer Center between December 2015 and August 2017, data cutoff in January 2019. Here, CD274 is linked to non-small cell lung carcinoma.